- 中文名稱
Ep大鼠uzumab 生物類似藥, CD22 單克隆抗體
- 英文名字
- Epratuzumab Biosimilar, CD22 Monoclonal Antibody
- 供應商
- Promab
- 產品貨號
- PMB-B00039
- 產品報價
- ￥詢價/1mg/5mg/20mg
- 產品說明書
- 點擊查看
- 購買方式
- 90%產品中國有現貨庫存。銀行轉賬、電匯、支票、現金，在線支付寶及網銀支付，或直接與我們電話聯系400-6800-868
- 產品新聞
- 背景資料
- Epratuzumab Biosimilar uses the same protein sequences as the therapeutic antibody epratuzumab.nnEpratuzumab is a humanized monoclonal antibody derived from the murine IG2a monoclonal antibody, LL2 (EPB-2). This agent may subsequently be well matched for use in oncology and the treatment of inflammatory autoimmune disorders, such as lupus.nnEpratuzumab is a recombinant, humanized monoclonal antibody directed against CD22, a cell surface glycoprotein present on mature B-cells and on many types of malignant B-cells. It binds with high specificity to normal B-cells and B-cell tumors at the third Ig-like domain of CD22. After binding to CD22, epratuzumab's predominant antitumor activity appears to be mediated through antibody-dependent cellular cytotoxicity (ADCC).
- 應用類型
- Flow cytometry, animal model study
- 免疫原
- Human CD22
- 來源宿主
- CHO cells
- 反應性
- Human
- 保存建議
- Store at 4°C 1 month, store at -20°C to -70°C 12 month. protected from prolonged exposure to light. Avoid freeze/thaw cycles.
- 其他
- cluster of differentiation-22, SIGLEC-2, SIGLEC2
- 注意
-
該頁面的中文產品信息的翻譯，僅供參考。準確的產品信息請以廠家的英文說明書為準。下單前，請瀏覽說明書確認。
-
